These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom. BMJ; 1993 Aug; 307(6902):469-72. PubMed ID: 8400928 [TBL] [Abstract][Full Text] [Related]
7. Ropinirole: a review of its use in the management of Parkinson's disease. Matheson AJ; Spencer CM Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932 [TBL] [Abstract][Full Text] [Related]
8. [Problems of long-term levodopa therapy in Parkinson's disease]. Nakamura Y Nihon Rinsho; 1997 Jan; 55(1):65-71. PubMed ID: 9014425 [TBL] [Abstract][Full Text] [Related]
9. Ongoing challenges to finding people with Parkinson's disease for epidemiological studies: a comparison of population-level case ascertainment methods. Harris MA; Koehoorn M; Teschke K Parkinsonism Relat Disord; 2011 Jul; 17(6):464-9. PubMed ID: 21531606 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial. LeWitt PA; Hauser RA; Pahwa R; Isaacson SH; Fernandez HH; Lew M; Saint-Hilaire M; Pourcher E; Lopez-Manzanares L; Waters C; Rudzínska M; Sedkov A; Batycky R; Oh C; Lancet Neurol; 2019 Feb; 18(2):145-154. PubMed ID: 30663606 [TBL] [Abstract][Full Text] [Related]
11. Recurrent bilateral metatarsal "stress-and-insufficiency" fractures in a levodopa-treated young woman with Parkinson's disease. Verdet M; Nicolau J; Lefaucheur R; Maltête D; Derrey S; Daragon A Osteoporos Int; 2013 Mar; 24(3):1131-3. PubMed ID: 22875460 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease. Deleu D; Hanssens Y; Northway MG Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576 [TBL] [Abstract][Full Text] [Related]
13. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease. Clarke CE; Deane KH Cochrane Database Syst Rev; 2001; (1):CD001517. PubMed ID: 11279719 [TBL] [Abstract][Full Text] [Related]
14. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease. Clarke CE; Deane KH Cochrane Database Syst Rev; 2000; 2001(3):CD001517. PubMed ID: 10908504 [TBL] [Abstract][Full Text] [Related]
16. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease. Simioni AC; Dagher A; Fellows LK Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834 [TBL] [Abstract][Full Text] [Related]
17. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom. Lees AJ BMJ; 1995 Dec; 311(7020):1602-7. PubMed ID: 8555803 [TBL] [Abstract][Full Text] [Related]
18. Levodopa and the progression of Parkinson's disease. Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K; N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952 [TBL] [Abstract][Full Text] [Related]
19. Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease. Nyholm D; Klangemo K; Johansson A Eur J Neurol; 2012 Aug; 19(8):1079-85. PubMed ID: 22360705 [TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of Parkinson's disease with levodopa and other adjunctive drugs. Mizuno Y; Shimoda S; Origasa H J Neural Transm (Vienna); 2018 Jan; 125(1):35-43. PubMed ID: 28091751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]